We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bioenergy AF.(See LSE:SBLM) | LSE:BAL | London | Ordinary Share | VGG1119K1049 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.25 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Miscellaneous: Publication of disclosure Publication of disclosure pursuant to Art. 21 of the Swiss Stock Exchange Act Basel, 7 January, 2009. Notification by Bâloise-Holding, Aeschengraben 21, CH-4002 Basel, Switzerland. Bâloise-Holding hereby discloses that Barclays Plc, 1 Churchill Place, London, E14 5HP, UK, and its subsidiary companies - Barclays Global Investors Japan Ltd, Ebisu Prime Square Tower, 1-1-39 Hiroo, Shibuya-ku, Tokyo 150-8402, Japan - Barclays Global Investors Ltd, 1 Churchill Place, London E14 5HP, UK - Barclays Bank Plc, 1 Churchill Place, London E14 5HP, UK - Barclays Life Assurance Co Ltd, 1 Churchill Place, London E14 5HP, UK - Barclays Global Investors (Deutschland) AG, Max-Joseph Strasse 6, 80333 München, Germany - Barclays Global Investors NA, 400 Howard Street, San Francisco, California 94105-2618, USA - Barclays Global Fund Advisors, 400 Howard Street, San Francisco, California 94105-2618, USA - Barclays Global Investors Canada Ltd, BCE Place, 161 Bay Street, Suite 2500, Box 614, Toronto, Ontario M5J 2S1, Canada - Barclays Global Investors Australia Ltd, Level 43, Grosvenor Place, 225 George Street, Sydney, NSW 2000, Australia dropped below the threshold of 3% of the voting rights on 29 December 2008 through the sale of shares of Bâloise Holding. ------------------------------------------------ Head Office of the Baloise Group: Aeschengraben 21, CH-4002 Basel Internet: www.baloise.com (http://www.baloise.com/) E-mail: media.relations@baloise.com / investor.relations@baloise.com Investor Relations: Tel. +41 61 285 81 81 Fax +41 61 285 75 62 Media Relations: Tel. +41 61 285 84 67 Fax +41 61 285 90 06 ------------------------------------------------ Headquartered in Basel (Switzerland) and with operations in Continental Europe, the Baloise Group is a solution provider in the fields of insurance and provision for the future. The Group's strategic focus is on sustainable, profitable growth in preferred target segments. Its markets are Switzerland, Germany, Belgium, Luxembourg, Austria, Croatia and Serbia. The Baloise Group employs some 8,600 people. Bâloise-Holding registered shares are included in the Swiss Market Index (SMI). Publication of disclosure: http://marco3.newsbox.ch/publish/baloise/18_147/Offenlegung_Barclays_07_01_09_E.pdf --- END - Last touched by the Tensid Systems @ 2009-01-07 16:51:29 UTC ------------------------------------------------------------------------------- Provider: Tensid Ltd., Switzerland, http://www.tensid.ch Channel: newsbox.ch Contact: marco@tensid.ch or phone +41 41 763 00 50 -------------------------------------------------------------------------------
1 Year Bioenergy AF.(See LSE:SBLM) Chart |
1 Month Bioenergy AF.(See LSE:SBLM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions